UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

The American journal of psychiatry, 2017-03, Vol.174 (3), p.216-229

2017

Volltextzugriff (PDF)

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation

Current pharmaceutical design, 2012-11, Vol.18 (32), p.5131

2012

Volltextzugriff (PDF)

Altered gray matter morphometry and resting-state functional and structural connectivity in social anxiety disorder

Brain research, 2011-05, Vol.1388, p.167-177

2011

Volltextzugriff (PDF)

Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review

Advances in experimental medicine and biology, 2021-01, Vol.1264, p.29-45

2021

Volltextzugriff (PDF)

Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination

Scientific reports, 2020-03, Vol.10 (1), p.4075, Article 4075

2020

Volltextzugriff (PDF)

Charcot-Marie-Tooth disease, psychiatric indicators and quality of life: a systematic review

ASN neuro, 2014-05, Vol.6 (3), p.185-192

2014

Volltextzugriff (PDF)

Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans

European neuropsychopharmacology, 2015-04, Vol.25 (4), p.483-492

2015

Volltextzugriff (PDF)

Do psychiatric comorbidities predict postoperative seizure outcome in temporal lobe epilepsy surgery?

Epilepsy & behavior, 2009-03, Vol.14 (3), p.529-534

2009

Volltextzugriff (PDF)

Role of Methylene Blue in Trauma Neuroprotection and Neuropsychiatric Diseases

CNS & neurological disorders drug targets, 2016-01, Vol.15 (8), p.976

2016

Volltextzugriff (PDF)

Neuroimaging in social anxiety disorder: A systematic review of the literature

Progress in neuro-psychopharmacology & biological psychiatry, 2010-05, Vol.34 (4), p.565-580

2010

Volltextzugriff (PDF)

Psychedelic Medicines in Major Depression: Progress and Future Challenges

Advances in experimental medicine and biology, 2021, Vol.1305, p.515-533

2021

Volltextzugriff (PDF)

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma

Mediators of Inflammation, 2015-01, Vol.2015 (1), p.538670-538670

2015

Volltextzugriff (PDF)

Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930–March 9, 2023) and his legacy for Brazilian pharmacology

Revista brasileira de psiquiatria, 2023, Vol.45 (3), p.201-202

2023

Volltextzugriff (PDF)

Neuroimaging of major depression in Parkinson's disease: Cortical thickness, cortical and subcortical volume, and spectroscopy findings

Journal of psychiatric research, 2017-07, Vol.90, p.40-45

2017

Volltextzugriff (PDF)

Oxytocin does not improve performance of patients with schizophrenia and healthy volunteers in a facial emotion matching task

Psychiatry research, 2014-12, Vol.220 (1), p.125-128

2014

Volltextzugriff (PDF)

Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week

Schizophrenia research, 2015-03, Vol.162 (1), p.211-215

2015

Volltextzugriff (PDF)

Brain functional and perfusional alterations in schizophrenia: an arterial spin labeling study

Psychiatry research. Neuroimaging, 2018-02, Vol.272, p.71-78

2018

Volltextzugriff (PDF)

Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia

Schizophrenia research, 2015-02, Vol.161 (2), p.439-445

2015

Volltextzugriff (PDF)

Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis

Schizophrenia research, 2011-01, Vol.125 (1), p.1-12

2011

Volltextzugriff (PDF)

Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems

Schizophrenia research, 2014-11, Vol.159 (2), p.558-559

2014

Volltextzugriff (PDF)

Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice

IBRO neuroscience reports, 2024-12, Vol.17, p.87-95

2024

Volltextzugriff (PDF)

Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder

Neuroscience letters, 2006-09, Vol.404 (3), p.276-281

2006

Volltextzugriff (PDF)

Adhesio interthalamica alterations in schizophrenia spectrum disorders: A systematic review and meta-analysis

Progress in neuro-psychopharmacology & biological psychiatry, 2011-06, Vol.35 (4), p.877-886

2011

Volltextzugriff (PDF)

Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain

Revista brasileira de psiquiatria, 2013-12, Vol.35 (4), p.380-386

2013

Volltextzugriff (PDF)

Intoxicación por ayahuasca

Medicina clínica, 2017, Vol.149 (10), p.461-462

2017

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(120)

Publikationsform

Artikel
(149)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation

Altered gray matter morphometry and resting-state functional and structural connectivity in social anxiety disorder

Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review

Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination

Charcot-Marie-Tooth disease, psychiatric indicators and quality of life: a systematic review

Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans

Do psychiatric comorbidities predict postoperative seizure outcome in temporal lobe epilepsy surgery?

Role of Methylene Blue in Trauma Neuroprotection and Neuropsychiatric Diseases

Neuroimaging in social anxiety disorder: A systematic review of the literature

Psychedelic Medicines in Major Depression: Progress and Future Challenges

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma

Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930–March 9, 2023) and his legacy for Brazilian pharmacology

Neuroimaging of major depression in Parkinson's disease: Cortical thickness, cortical and subcortical volume, and spectroscopy findings

Oxytocin does not improve performance of patients with schizophrenia and healthy volunteers in a facial emotion matching task

Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week

Brain functional and perfusional alterations in schizophrenia: an arterial spin labeling study

Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia

Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis

Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems

Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice

Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder

Adhesio interthalamica alterations in schizophrenia spectrum disorders: A systematic review and meta-analysis

Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain

Intoxicación por ayahuasca

Suchergebnisse filtern